Elixinol Global Valuation
| ELLXF Stock | USD 0.03 0.02 700.00% |
Elixinol Global seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Elixinol Global from reviewing the firm fundamentals such as Profit Margin of (1.72) %, current valuation of 2.06 M, and Shares Outstanding of 316.27 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Elixinol Global's price fluctuation is out of control at this time. Calculation of the real value of Elixinol Global is based on 3 months time horizon. Increasing Elixinol Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elixinol pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Elixinol Global. Since Elixinol Global is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elixinol Pink Sheet. However, Elixinol Global's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0256 | Real 0.0208 | Hype 0.03 | Naive 0.0311 |
The real value of Elixinol Pink Sheet, also known as its intrinsic value, is the underlying worth of Elixinol Global Company, which is reflected in its stock price. It is based on Elixinol Global's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Elixinol Global's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Elixinol Global helps investors to forecast how Elixinol pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elixinol Global more accurately as focusing exclusively on Elixinol Global's fundamentals will not take into account other important factors: Elixinol Global Total Value Analysis
Elixinol Global is currently anticipated to have takeover price of 2.06 M with market capitalization of 6.5 M, debt of 250 K, and cash on hands of 6.93 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Elixinol Global fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.06 M | 6.5 M | 250 K | 6.93 M |
Elixinol Global Investor Information
About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elixinol Global recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. Elixinol Global is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Elixinol Global Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elixinol Global has an asset utilization ratio of 55.77 percent. This implies that the Company is making $0.56 for each dollar of assets. An increasing asset utilization means that Elixinol Global is more efficient with each dollar of assets it utilizes for everyday operations.Elixinol Global Ownership Allocation
Elixinol Global holds a total of 316.27 Million outstanding shares. Elixinol Global shows 15.67 percent of its outstanding shares held by insiders and 4.83 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Elixinol Global Profitability Analysis
The company reported the revenue of 14.13 M. Net Loss for the year was (17.02 M) with profit before overhead, payroll, taxes, and interest of 4.9 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Elixinol Global's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Elixinol Global and how it compares across the competition.
About Elixinol Global Valuation
The pink sheet valuation mechanism determines Elixinol Global's current worth on a weekly basis. Our valuation model uses a comparative analysis of Elixinol Global. We calculate exposure to Elixinol Global's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elixinol Global's related companies.Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. Elixinol Wellness operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Elixinol Global's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Elixinol Global's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Elixinol Global's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Elixinol Global's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Elixinol Global's revenue streams: Identify Elixinol Global's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Elixinol Global's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Elixinol Global's growth potential: Evaluate Elixinol Global's management, business model, and growth potential.
- Determine Elixinol Global's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Elixinol Global's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Elixinol Global Growth Indicators
Investing in growth stocks can be very risky. If the company such as Elixinol Global does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 315.9 M | |
| Retained Earnings | -208.1 M |
Complementary Tools for Elixinol Pink Sheet analysis
When running Elixinol Global's price analysis, check to measure Elixinol Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Global is operating at the current time. Most of Elixinol Global's value examination focuses on studying past and present price action to predict the probability of Elixinol Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Global's price. Additionally, you may evaluate how the addition of Elixinol Global to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |